FDA Investigating Abbot Formula After Possible Link to Infant’s Death


The U.S. Food and Drug Administration (FDA) announced that it would launch an investigation into Abbott Laboratories after another child was killed, possibly due to the use of the Abbott Formula.

The FDA released a statement on Wednesday indicating that it would investigate the death after receiving a complaint.

“The agency was notified of one additional consumer complaint on June 10, 2022, that resulted in infant death in January 2022. The agency has initiated an investigation, given that the complaint referenced that the infant had consumed an Abbott product,” the agency said in the statement.

Bloomberg reports that the company said there were no conclusive findings or evidence suggesting a causal link between Abbott’s formulas, and the case.

Abbott closed its Michigan branch in February after receiving reports of four babies who fell ill and two babies who died reportedly after consuming Abbott products. The FDA, however, was unable to determine conclusively after the agency’s investigation that the Abbott formula was in fact the cause of death and illness in these infants.

Abbott produces all of these products: Similac, PediaSure, Pedialyte, Ensure, ZonePerfect, and Glucerna.

Abbott released a Twitter statement in response to the matter.

The FDA stated that they are currently investigating the latest consumer complaint. As they learn more, they will inform the public.